Arsenal Capital raises $5.4 billion for two new funds

Fund VI will focus on investments in industrials and healthcare businesses with proven technologies and solutions positioned to deliver high performance and value-add to their customers

Strong execution in Q2 drives full-year 2022 guidance upgrade for Sanofi

Lupin Diagnostics launches its first regional reference lab in Patna

Expanding diagnostics footprint in East India

Strides receives USFDA approval for Ibuprofen OTC oral suspension

Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.

Sanofi India appoints Preeti Futnani as GM, Vaccines

Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.

Motilal Oswal Private Equity (MOPE) invests in Pathkind Diagnostics

A primary investment of Rs 194.4 crore has been made

TwistPak: Mixing platform for swine vaccines brings convenience and flexibility

Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being

Cipla posts consolidated PAT of Rs. 362.07 crore in Q4 FY2022

Cipla has reported consolidated financial results for the period ended March 31, 2022

Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion

Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need

Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore

The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings